Showing results (31-40 of 1,083) with videos related to
Sort By:
Pageof 109
American Heart Journal|July 31, 2008
Pharmacology of emerging novel platelet inhibitorsDominick J Angiolillo, Piera CapranzanoAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 27, 2010
Platelet P2Y₁₂ receptor inhibition: an update on clinical drug developmentDavid Vivas, Dominick J AngiolilloBest Practice & Research. Clinical Endocrinology & Metabolism|June 13, 2009
Aspirin and clopidogrel: efficacy and resistance in diabetes mellitusDominick J Angiolillo, Siva SuryadevaraNature Reviews. Cardiology|October 8, 2014
Novel antiplatelet agents in acute coronary syndromeFrancesco Franchi, Dominick J AngiolilloCirculation|October 13, 2016
Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes MellitusDavide Capodanno, Dominick J AngiolilloJournal of Thrombosis and Thrombolysis|August 29, 2014
Percutaneous coronary intervention and atrial fibrillation: the triple therapy dilemmaJung Rae Cho, Dominick J AngiolilloAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 25, 2013
Antiplatelet and anticoagulant therapy for atherothrombotic disease: the role of current and emerging agentsDominick J Angiolillo, José Luis FerreiroAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 10, 2016
Clinical Pharmacology and Cardiovascular Safety of NaproxenDominick J Angiolillo, Steven M WeismanRevista Espanola De Cardiologia|January 22, 2010
Platelet adenosine diphosphate P2Y12 receptor antagonism: benefits and limitations of current treatment strategies and future directionsDominick J Angiolillo, José Luis FerreiroCurrent Pharmaceutical Design|June 26, 2012
Challenges and perspectives of antiplatelet therapy in patients with diabetes mellitus and coronary artery diseaseJose Luis Ferreiro, Dominick J AngiolilloPageof 109